Pharma's Almanac TV
PA TV
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Follow the Journey
Companies On The Road
Follow The Artist
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2021 Sterile Drug Market Report
2021 API Market Report
2020 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
More+
Staffing
Media Kit
Roche
Articles Available
Can't find what you're looking for? Try our
advanced search
.
COVID-19 Testing
Roche Obtains CE Mark for the SARS-CoV-2 Antigen Self Test Nasal Allowing for Rapid Self Testing of COVID-19 At Home
PR-M06-21-027
Production
Novartis to Produce Roche's Actemra/RoActemra
PR-M04-21-017
Collaboration
Blueprint Medicines Announces Global Collaboration with Roche to Develop and Commercialize Pralsetinib for Patients with RET-Altered Cancers
PR-M07-20-NI-023
Clinical Trials
New Data from Phase IIIb Study Reinforces Safety Profile of Roche’s Hemlibra in People with Haemophilia A
PR-M07-20-NI-020
COVID-19 Antibody Testing
Roche's Highly Accurate Antibody Test for COVID-19 Goes Live at More than 20 Initial Lab Sites in the U.S.
PR-M05-20-NI-035
FDA Approval
Roche Receives FDA Approval for Cobas HPV Test to Identify Women at Risk for Cervical Cancer
PR-M04-20-NI-031
COVID-19
Roche Initiates Phase III Clinical Trial of Actemra/RoActemra in Patients with Severe COVID-19 Pneumonia
PR-M03-20-NI-030
Roche Ships 400,000 Coronavirus Test Kits to U.S.
PR-M03-20-NI-027
M&A
Promedior Announces Completion of Acquisition by Roche
PR-M02-20-NI-020
Clinical Trials
Roche’s Risdiplam Meets Primary Endpoint in Pivotal FIREFISH Trial
PR-M01-20-NI-036
M&A
Federal Trade Commission Closes Investigation of Roche Holding AG’s Proposed Acquisition of Spark Therapeutics, Inc.
PR-M12-19-NI-024
Commercial Agreement
Dicerna™ Enters Agreement with Roche to Develop and Commercialize DCR-HBVS for the Treatment of Chronic Hepatitis B Virus (HBV) Infection
PR-M10-19-NI-050
Business
Roche Acquisition of Spark Therapeutics Delayed Again
PAO-M08-19-NI-028
Oncology
Roche Receives CHMP Positive Opinion for New Tecentriq-based Combination Therapy as an Initial Treatment for Most Common Form of Advanced Lung Cancer
PR-M08-19-NI-004
Leadership
Changes in Roche's Board of Directors and Corporate Executive Committee
PR-M06-19-NI-008
Approval
Roche Gets New EU Approval for MabThera
PAO-M03-19-NI-027
Gene Therapy
Roche Moves into the Gene Therapy Space
PAO-M03-19-NI-006
Generics
Roche Counters Generic Competition with New Cancer Treatments
PAO-M02-19-NI-022
Companion Diagnostics
Roche to Develop Companion Diagnostic Test to Help Identify Patients Eligible for Anti-PD-1 Therapy Based on Biomarker Expression, Not Location, of Solid Tumors
PR-M12-18-NI-050
FDA Approval
FDA Approves Roche's Tecentriq in Combination with Avastin and Chemotherapy for the Initial Treatment of People with a Specific Type of Metastatic Lung Cancer
PR-M12-18-NI-041
Appointment
Roche Exec Moves to Gilead
PAO-M12-18-NI-010
Partnership
Immunocore Expands Partnership with Roche
PAO-M11-18-NI-017
Digital Health
Roche Collaborates in Digital Health
PAO-M10-18-NI-006
Blood Test
New Blood Test from Roche Detects Common Gene Mutations
PAO-M09-18-NI-022
